Towards interoperability through inter-enterprise collaboration architectures

Most enterprise architectures published so far are capable of generating reasonably good descriptive models for individual enterprises to enable integration, organization and synchronization of enterprise elements: organizational structure, business processes, information systems and technology infrastructure, among others. However, research in this field applied to the extended enterprise or inter-enterprise architectures that takes into account the growing trend towards complex collaborative environments is very scarce. In this sense, this article seeks to analyze, link and synthesize the researches that has addressed the disciplines of enterprise architecture and business collaboration, in order to identify possible future research needs from the conceptualization made.Vargas, A.; Boza Garcia, A.; Cuenca, L. (2011). Towards interoperability through inter-enterprise collaboration architectures. En On the Move to Meaningful Internet Systems: OTM 2011 Workshops. Springer Verlag (Germany). 7046:102-111. doi:10.1007/978-3-642-25126-9_18S1021117046Adam, O., Hofer, A., Zang, S., Hammer, C., Jerrentrup, M., Leinenbach, S.: A Collaboration Framework for Cross-enterprise Business Process Management. In: First International Conference on Interoperability of Enterprise Software and Application, Geneva (2005)Chalmeta, R., Grangel, R.: ARDIN extension for virtual enterprise integration. The Journal of Systems and Software 67, 141–152 (2003)Choi, Y., Kang, D., Chae, H., Kim, K.: An enterprise architecture framework for collaboration of virtual enterprise chains. The International Journal of Advanced Manufacturing Technology 35, 1065–1078 (2008)Schekkerman, J.: Extended Enterprise Architecture Framework Essentials Guide. Institute For Enterprise Architecture Developments, IFEAD (2006), http://www.enterprise-architecture.info/index.htmISO 15704. Industrial automation systems - Requirements for enterprise-reference architectures and methodologies.: International Organization for Standardization (2000)Kosanke, K., Vernadat, F., Zelm, M.: CIMOSA: Enterprise engineering and integration. Computers in Industry 40, 83–97 (1999)Cuenca, L.: Marco arquitectónico para la propuesta IE-GIP. Extensión de la arquitectura CIMOSA. Aplicación a una empresa del sector cerámico. PhD thesis. Universidad Politécnica de ValenciaMolina, A., Panetto, H., Chen, D., Whitman, L.: Enterprise Integration and Networking: challenges and trends. Studies in Informatics and Control 16(4), 353–368 (2007)Ortiz, A., Lario, F., Ros, L.: Enterprise Integration—Business Processes Integrated Management: a proposal for a methodology to develop Enterprise Integration Programs. Computers in Industry 40, 155–171 (1999)Chalmeta, R., Campos, C., Grangel, R.: References architectures for enterprise integration. The Journal of Systems and Software 57, 175–191 (2001)Vernadat, F.: Enterprise modeling and integration (EMI): Current status and research perspectives. Annual Reviews in Control 26, 15–25 (2002)Williams, T., Li, H.: PERA and GERAM enterprise reference architectures in enterprise integration. Information Infrastructure Systems for Manufacturing, 1–27 (1998)Lankhorst, M.: Enterprise Architecture at Work: Modelling, Communication and Analysis. Springer, Heidelberg (2009)Arango, M., Londoño, J., Zapata, J.: Arquitectura empresarial- Una visión general. Revista Ingenierías Universidad de Medellín 9(16), 101–111 (2010)Bernard, S.: An introduction to enterprise architecture. AuthorHouse, Bloomington (2005)Cuenca, L., Ortiz, A., Boza, A.: Arquitectura de Empresa. Visión General. In: IX Congreso de Ingeniería de Organización, Gijón (2005)Maya, E.: Arquitectura empresarial: un nuevo reto para las empresas de hoy. Centro de Investigación de las Telecomunicaciones. INTERACTIC: Interacción con la información (2010), http://www.interactic.org.co/THE OPEN GROUP.: ARCHIMATE, The Power of Enterprise Architecture (2009), http://www.archimate.org/en/home/Stelzer, D.: Enterprise Architecture Principles: Literature Review and Research Directions. In: Dan, A., Gittler, F., Toumani, F. (eds.) ICSOC/ServiceWave 2009. LNCS, vol. 6275, pp. 12–21. Springer, Heidelberg (2010)Schekkerman, J.: Enterprise architecture validation. Achieving business-aligned and validated enterprise architectures. Institute For Enterprise Architecture Developments, IFEAD (2004), http://www.enterprise-architecture.info/index.htmKosanke, K.: CIMOSA Primer on key concepts, purpose and business value (1996), http://cimosa.cnt.pl/Chen, D., Vallespir, B., Doumeingts, G.: GRAI integrated methodology and its mapping onto generic enterprise reference architecture and methodology. Computers in Industry 33, 387–394 (1997)Rathwell, G.: PERA Enterprise Integration Web Site (2005), http://www.pera.net/Williams, T., Rathwell, G., Li, H.: A handbook on master planning and implementation for enterprise integration programs. PERA Enterprise Integration Web Site (2001), http://www.pera.net/IFIP.: GERAM: Generalised Enterprise Reference Architecture and Methodology. International Federation for Information Processing (1999), http://dl.ifip.org/index.php/index/indexOrtiz, A.: Propuesta para el Desarrollo de Programas de Integración Empresarial en Empresas Industriales. Aplicación a una Empresa del Sector Cerámico. Universidad Politécnica de Valencia (1998)Cuenca, L., Boza, A., Ortiz, A.: Architecting business and IS/IT strategic alignment for extend enterprises. Studies in Informatics and Control 20(1), 7–18 (2011)The Open Group (2011), https://www.opengroup.org/index.htmGrangel, R.: Propuesta para el Modelado del Conocimiento Empresarial. PhD thesis Universidad Jaume I de Castello (2007)Scheer, A., Schneider, K.: ARIS – Architecture of Integrated Information. Handbook on Architectures of Information Systems. International Handbooks on Information Systems 3, 605–623 (2006)ISO/CEN 19439. Enterprise integration - Framework for enterprise modelling.: International Organization for Standardization (2006)Stadtler, H., Kilger, C.: Supply Chain Management and advance planning. Concepts, Models, Sofware and Cases Studies. Springer, Heidelberg (2002)Alarcón, F., Ortiz, A., Alemany, M., Lario, F.: Planificación Colaborativa en un contexto de varias Cadenas de Suministro: ventajas y desventajas. In: VIII Congreso de Ingeniería de Organización, Leganés, pp. 857–866 (2004)Alarcón, F.: Desarrollo de una Arquitectura para la definición del proceso de Comprometer Pedidos en contextos de Redes de Suministro Colaborativas. Aplicación a una Red compuesta por Cadenas de Suministro en los Sectores Cerámico y del Mueble. PhD thesis Universidad Politécnica de Valencia (2005)Petersen, K., Ragatz, G., Monczka, R.: An Examination of Collaborative Planning Effectiveness and Supply Chain Performance. The Journal of Supply Chain Management 41(2), 14–25 (2005)Ribas, I., Companys, R.: Estado del arte de la planificación colaborativa en la cadena de suministro: Contexto determinista e incierto. Intangible Capital, 91–121 (2007)Ribas, I., Lario, F., Companys, R.: Modelos para la planificación colaborativa en la cadena de suministro: contexto determinista e incierto. In: Congreso de ingeniería de organización, Valencia, pp. 1–10 (2006)Dudek, G.: Collaborative Planning in Supply Chains. Supply Chain Management and Collaborative Planning. Springer, Heidelberg (2009)Stadtler, H.: A framework for collaborative planning and state-of-the-art. OR Spectrum 31, 5–30 (2009)Kilger, C., Reuter, B., Stadtler, H.: Collaborative Planning. In: Stadtler, H., Kilger, C. (eds.) Supply Chain Management and Advanced Planning-—Concepts, Models Software and Case Studies, pp. 263–284. Springer, Heidelberg (2008)Audy, J., Lehoux, N., D’Amours, S.: A framework for an efficient implementation of logistics collaborations. International Transactions in Operational Research, 1–25 (2010)Zachman, J.: A Framework for Information Systems Architecture. IBM Systems Journal 26(3), 454–470 (1987

The Effect of Epstein-Barr Virus Latent Membrane Protein 2 Expression on the Kinetics of Early B Cell Infection

Infection of human B cells with wild-type Epstein-Barr virus (EBV) in vitro leads to activation and proliferation that result in efficient production of lymphoblastoid cell lines (LCLs). Latent Membrane Protein 2 (LMP2) is expressed early after infection and previous research has suggested a possible role in this process. Therefore, we generated recombinant EBV with knockouts of either or both protein isoforms, LMP2A and LMP2B (Δ2A, Δ2B, Δ2A/Δ2B) to study the effect of LMP2 in early B cell infection. Infection of B cells with Δ2A and Δ2A/Δ2B viruses led to a marked decrease in activation and proliferation relative to wild-type (wt) viruses, and resulted in higher percentages of apoptotic B cells. Δ2B virus infection showed activation levels comparable to wt, but fewer numbers of proliferating B cells. Early B cell infection with wt, Δ2A and Δ2B viruses did not result in changes in latent gene expression, with the exception of elevated LMP2B transcript in Δ2A virus infection. Infection with Δ2A and Δ2B viruses did not affect viral latency, determined by changes in LMP1/Zebra expression following BCR stimulation. However, BCR stimulation of Δ2A/Δ2B cells resulted in decreased LMP1 expression, which suggests loss of stability in viral latency. Long-term outgrowth assays revealed that LMP2A, but not LMP2B, is critical for efficient long-term growth of B cells in vitro. The lowest levels of activation, proliferation, and LCL formation were observed when both isoforms were deleted. These results suggest that LMP2A appears to be critical for efficient activation, proliferation and survival of EBV-infected B cells at early times after infection, which impacts the efficient long-term growth of B cells in culture. In contrast, LMP2B did not appear to play a significant role in these processes, and long-term growth of infected B cells was not affected by the absence of this protein. © 2013 Wasil et al

T Cell Integrin Overexpression as a Model of Murine Autoimmunity

Integrin adhesion molecules have important adhesion and signaling functions. They also play a central role in the pathogenesis of many autoimmune diseases. Over the past few years we have described a T cell adoptive transfer model to investigate the role of T cell integrin adhesion molecules in the development of autoimmunity. This report summarizes the methods we used in establishing this murine model. By treating murine CD4+ T cells with DNA hypomethylating agents and by transfection we were able to test the in vitro effects of integrin overexpression on T cell autoreactive proliferation, cytotoxicity, adhesion and trafficking. Furthermore, we showed that the ability to induce in vivo autoimmunity may be unique to the integrin lymphocyte function associated antigen-1 (LFA-1)

c-Rel Deficiency Increases Caspase-4 Expression and Leads to ER Stress and Necrosis in EBV-Transformed Cells

LMP1-mediated activation of nuclear factor of kappaB (NF-κB) is critical for the ligand independent proliferation and cell survival of in vitro EBV-transformed lymphoblastoid cell lines (LCLs). Previous experiments revealed that a majority of LMP1-dependent responses are regulated by NF-κB. However, the extent that individual NF-κB family members are required for these responses, in particular, c-Rel, whose expression is restricted to mature hematopoietic cells, remains unclear. Here we report that low c-Rel expression in LCLs derived from a patient with hyper-IgM syndrome (Pt1), resulted in defects in proliferation and cell survival. In contrast to studies that associated loss of NF-κB with increased apoptosis, Pt1 LCLs failed to initiate apoptosis and alternatively underwent autophagy and necrotic cell death. Whereas the proliferation defect appeared linked to a c-Rel-associated decrease in c-myc expression, identified pro-survival and pro-apoptotic targets were expressed at or near control levels consistent with the absence of apoptosis. Ultrastructural examination of Pt1 LCLs revealed a high level of cellular and ER stress that was further supported by gene expression profiling showing the upregulation of several genes involved in stress and inflammation. Apoptosis-independent cell death was accompanied by increased expression of the inflammatory marker, caspase-4. Using gene overexpression and siRNA knockdown we demonstrated that levels of c-Rel directly modulated expression of caspase-4 as well as other ER stress genes. Overall, these findings reveal the importance of c-Rel in maintaining LCL viability and that decreased expression results in ER stress and a default response leading to necrotic cell death

The Bayh-Dole Act of 1980 and University–Industry Technology Transfer: A Model for Other OECD Governments?

Recent initiatives by a number of OECD governments suggest considerable interest in emulating the Bayh-Dole Act of 1980, a piece of legislation that is widely credited with stimulating significant growth in university--industry technology transfer and research collaboration in theUS. We examine the effects of Bayh-Dole on university--industry collaboration and technology transfer in the US, emphasizing the lengthy history of both activities prior to 1980 and noting the extent to which these activities are rooted in the incentives created by the unusual scale and structure (by comparison with Western Europe or Japan) of the US higher education system. Efforts at “emulation” of the Bayh-Dole policy elsewhere in the OECD are likely to have modest success at best without greater attention to the underlying structural differences among the higher education systems of these nations.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/43108/1/10961_2004_Article_5384361.pd

Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Κb Activation

Epstein-Barr virus (EBV) is associated with several types of cancers including Hodgkin's lymphoma (HL) and nasopharyngeal carcinoma (NPC). EBV-encoded latent membrane protein 1 (LMP1), a multifunctional oncoprotein, is a powerful activator of the transcription factor NF-κB, a property that is essential for EBV-transformed lymphoblastoid cell survival. Previous studies reported LMP1 sequence variations and induction of higher NF-κB activation levels compared to the prototype B95-8 LMP1 by some variants. Here we used biopsies of EBV-associated cancers and blood of individuals included in the Swiss HIV Cohort Study (SHCS) to analyze LMP1 genetic diversity and impact of sequence variations on LMP1-mediated NF-κB activation potential. We found that a number of variants mediate higher NF-κB activation levels when compared to B95-8 LMP1 and mapped three single polymorphisms responsible for this phenotype: F106Y, I124V and F144I. F106Y was present in all LMP1 isolated in this study and its effect was variant dependent, suggesting that it was modulated by other polymorphisms. The two polymorphisms I124V and F144I were present in distinct phylogenetic groups and were linked with other specific polymorphisms nearby, I152L and D150A/L151I, respectively. The two sets of polymorphisms, I124V/I152L and F144I/D150A/L151I, which were markers of increased NF-κB activation in vitro, were not associated with EBV-associated HL in the SHCS. Taken together these results highlighted the importance of single polymorphisms for the modulation of LMP1 signaling activity and demonstrated that several groups of LMP1 variants, through distinct mutational paths, mediated enhanced NF-κB activation levels compared to B95-8 LMP1

Genetic Analysis of Human Traits In Vitro: Drug Response and Gene Expression in Lymphoblastoid Cell Lines

Lymphoblastoid cell lines (LCLs), originally collected as renewable sources of DNA, are now being used as a model system to study genotype–phenotype relationships in human cells, including searches for QTLs influencing levels of individual mRNAs and responses to drugs and radiation. In the course of attempting to map genes for drug response using 269 LCLs from the International HapMap Project, we evaluated the extent to which biological noise and non-genetic confounders contribute to trait variability in LCLs. While drug responses could be technically well measured on a given day, we observed significant day-to-day variability and substantial correlation to non-genetic confounders, such as baseline growth rates and metabolic state in culture. After correcting for these confounders, we were unable to detect any QTLs with genome-wide significance for drug response. A much higher proportion of variance in mRNA levels may be attributed to non-genetic factors (intra-individual variance—i.e., biological noise, levels of the EBV virus used to transform the cells, ATP levels) than to detectable eQTLs. Finally, in an attempt to improve power, we focused analysis on those genes that had both detectable eQTLs and correlation to drug response; we were unable to detect evidence that eQTL SNPs are convincingly associated with drug response in the model. While LCLs are a promising model for pharmacogenetic experiments, biological noise and in vitro artifacts may reduce power and have the potential to create spurious association due to confounding

Separation – integration – and now …? - An historical perspective on the relationship between German management accounting and financial accounting

German accounting has traditionally followed a dual ledger approach with strictly separated internal cost accounting, as the basis for management information, and external financial accounting focusing on creditor protection and based on the commercial law. However, the increased adoption of integrated accounting system implies a significant change in the relationship between financial and management accounting systems. We use Hegelian dialectic to trace the historical development of German accounting from separated systems towards antithetical propositions of full integration, and the emergence of partial integration as the synthesis of this transformation process. For this reason, our paper provides a comprehensive analysis of the literature on the relationship between financial and management accounting in Germany. On this basis, we elaborate how financial accounting in Germany has been shaped by its economic context and legislation, and how financial accounting – accompanied by institutional pressures – in turn influenced management accounting. We argue that the changing relationship between management and financial accounting in the German context illustrates how current accounting practice is shaped not only by its environment, but also by its historical path. Based on this reasoning, we discuss several avenues for future research

Design and Organization of the Dexamethasone, Light Anesthesia and Tight Glucose Control (DeLiT) Trial: a factorial trial evaluating the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery

<p>Abstract</p> <p>Background</p> <p>The perioperative period is characterized by an intense inflammatory response. Perioperative inflammation promotes postoperative morbidity and increases mortality. Blunting the inflammatory response to surgical trauma might thus improve perioperative outcomes. We are studying three interventions that potentially modulate perioperative inflammation: corticosteroids, tight glucose control, and light anesthesia.</p> <p>Methods/Design</p> <p>The DeLiT Trial is a factorial randomized single-center trial of dexamethasone vs placebo, intraoperative tight vs. conventional glucose control, and light vs deep anesthesia in patients undergoing major non-cardiac surgery. Anesthetic depth will be estimated with Bispectral Index (BIS) monitoring (Aspect medical, Newton, MA). The primary outcome is a composite of major postoperative morbidity including myocardial infarction, stroke, sepsis, and 30-day mortality. C-reactive protein, a measure of the inflammatory response, will be evaluated as a secondary outcome. One-year all-cause mortality as well as post-operative delirium will be additional secondary outcomes. We will enroll up to 970 patients which will provide 90% power to detect a 40% reduction in the primary outcome, including interim analyses for efficacy and futility at 25%, 50% and 75% enrollment.</p> <p>Discussion</p> <p>The DeLiT trial started in February 2007. We expect to reach our second interim analysis point in 2010. This large randomized controlled trial will provide a reliable assessment of the effects of corticosteroids, glucose control, and depth-of-anesthesia on perioperative inflammation and morbidity from major non-cardiac surgery. The factorial design will enable us to simultaneously study the effects of the three interventions in the same population, both individually and in different combinations. Such a design is an economically efficient way to study the three interventions in one clinical trial vs three.</p> <p>Trial registration</p> <p><b>This trial is registered at </b>Clinicaltrials.gov <b>#</b>: NTC00433251</p

C-Terminal Region of EBNA-2 Determines the Superior Transforming Ability of Type 1 Epstein-Barr Virus by Enhanced Gene Regulation of LMP-1 and CXCR7

Type 1 Epstein-Barr virus (EBV) strains immortalize B lymphocytes in vitro much more efficiently than type 2 EBV, a difference previously mapped to the EBNA-2 locus. Here we demonstrate that the greater transforming activity of type 1 EBV correlates with a stronger and more rapid induction of the viral oncogene LMP-1 and the cell gene CXCR7 (which are both required for proliferation of EBV-LCLs) during infection of primary B cells with recombinant viruses. Surprisingly, although the major sequence differences between type 1 and type 2 EBNA-2 lie in N-terminal parts of the protein, the superior ability of type 1 EBNA-2 to induce proliferation of EBV-infected lymphoblasts is mostly determined by the C-terminus of EBNA-2. Substitution of the C-terminus of type 1 EBNA-2 into the type 2 protein is sufficient to confer a type 1 growth phenotype and type 1 expression levels of LMP-1 and CXCR7 in an EREB2.5 cell growth assay. Within this region, the RG, CR7 and TAD domains are the minimum type 1 sequences required. Sequencing the C-terminus of EBNA-2 from additional EBV isolates showed high sequence identity within type 1 isolates or within type 2 isolates, indicating that the functional differences mapped are typical of EBV type sequences. The results indicate that the C-terminus of EBNA-2 accounts for the greater ability of type 1 EBV to promote B cell proliferation, through mechanisms that include higher induction of genes (LMP-1 and CXCR7) required for proliferation and survival of EBV-LCLs